Global Immunotherapy Market Research Report 2019

Table of Contents

Executive Summary

1 Immunotherapy Market Overview

• 1.1 Product Overview and Scope of Immunotherapy
• 1.2 Immunotherapy Segment by Type
  • 1.2.1 Global Immunotherapy Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Monoclonal Antibodies
  • 1.2.3 Therapeutic Vaccines
  • 1.2.4 Checkpoint Inhibitors
  • 1.2.5 Non-Specific Immunotherapy
• 1.3 Immunotherapy Segment by Application
  • 1.3.1 Immunotherapy Consumption Comparison by Application (2014-2025)
  • 1.3.2 Oncology
  • 1.3.3 Inflammation
  • 1.3.4 Central Nervous System
  • 1.3.5 Others
• 1.4 Global Immunotherapy Market by Region
  • 1.4.1 Global Immunotherapy Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Immunotherapy Market Size
  • 1.5.1 Global Immunotherapy Revenue (2014-2025)
  • 1.5.2 Global Immunotherapy Production (2014-2025)

2 Global Immunotherapy Market Competition by Manufacturers

• 2.1 Global Immunotherapy Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Immunotherapy Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Immunotherapy Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Immunotherapy Production Sites, Area Served, Product Types
• 2.5 Immunotherapy Market Competitive Situation and Trends
  • 2.5.1 Immunotherapy Market Concentration Rate
  • 2.5.2 Immunotherapy Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Immunotherapy Production Market Share by Regions

• 3.1 Global Immunotherapy Production Market Share by Regions
• 3.2 Global Immunotherapy Revenue Market Share by Regions (2014-2019)
• 3.3 Global Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Immunotherapy Production
  • 3.4.1 North America Immunotherapy Production Growth Rate (2014-2019)
  • 3.4.2 North America Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Immunotherapy Production
  • 3.5.1 Europe Immunotherapy Production Growth Rate (2014-2019)
  • 3.5.2 Europe Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Immunotherapy Production (2014-2019)
  • 3.6.1 China Immunotherapy Production Growth Rate (2014-2019)
  • 3.6.2 China Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Immunotherapy Production (2014-2019)
  • 3.7.1 Japan Immunotherapy Production Growth Rate (2014-2019)
  • 3.7.2 Japan Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Immunotherapy Consumption by Regions

• 4.1 Global Immunotherapy Consumption by Regions
• 4.2 North America Immunotherapy Consumption (2014-2019)
• 4.3 Europe Immunotherapy Consumption (2014-2019)
• 4.4 China Immunotherapy Consumption (2014-2019)
• 4.5 Japan Immunotherapy Consumption (2014-2019)

5 Global Immunotherapy Production, Revenue, Price Trend by Type

• 5.1 Global Immunotherapy Production Market Share by Type (2014-2019)
• 5.2 Global Immunotherapy Revenue Market Share by Type (2014-2019)
• 5.3 Global Immunotherapy Price by Type (2014-2019)
• 5.4 Global Immunotherapy Production Growth by Type (2014-2019)

6 Global Immunotherapy Market Analysis by Applications

• 6.1 Global Immunotherapy Consumption Market Share by Application (2014-2019)
• 6.2 Global Immunotherapy Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Immunotherapy Business

• 7.1 Abbvie
  • 7.1.1 Abbvie Immunotherapy Production Sites and Area Served
  • 7.1.2 Immunotherapy Product Introduction, Application and Specification
  • 7.1.3 Abbvie Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Amgen, Inc.
  • 7.2.1 Amgen, Inc. Immunotherapy Production Sites and Area Served
  • 7.2.2 Immunotherapy Product Introduction, Application and Specification
  • 7.2.3 Amgen, Inc. Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Biogen
  • 7.3.1 Biogen Immunotherapy Production Sites and Area Served
  • 7.3.2 Immunotherapy Product Introduction, Application and Specification
  • 7.3.3 Biogen Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Bristol-Myers Squibb
  • 7.4.1 Bristol-Myers Squibb Immunotherapy Production Sites and Area Served
  • 7.4.2 Immunotherapy Product Introduction, Application and Specification
  • 7.4.3 Bristol-Myers Squibb Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Celgene
  • 7.5.1 Celgene Immunotherapy Production Sites and Area Served
  • 7.5.2 Immunotherapy Product Introduction, Application and Specification
  • 7.5.3 Celgene Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Johnson & Johnson
  • 7.6.1 Johnson & Johnson Immunotherapy Production Sites and Area Served
  • 7.6.2 Immunotherapy Product Introduction, Application and Specification
  • 7.6.3 Johnson & Johnson Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Merck
  • 7.7.1 Merck Immunotherapy Production Sites and Area Served
  • 7.7.2 Immunotherapy Product Introduction, Application and Specification
  • 7.7.3 Merck Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Novartis
  • 7.8.1 Novartis Immunotherapy Production Sites and Area Served
  • 7.8.2 Immunotherapy Product Introduction, Application and Specification
  • 7.8.3 Novartis Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Pfizer
  • 7.9.1 Pfizer Immunotherapy Production Sites and Area Served
  • 7.9.2 Immunotherapy Product Introduction, Application and Specification
  • 7.9.3 Pfizer Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Roche
  • 7.10.1 Roche Immunotherapy Production Sites and Area Served
  • 7.10.2 Immunotherapy Product Introduction, Application and Specification
  • 7.10.3 Roche Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served

8 Immunotherapy Manufacturing Cost Analysis

• 8.1 Immunotherapy Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Immunotherapy
• 8.4 Immunotherapy Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Immunotherapy Distributors List
• 9.3 Immunotherapy Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Immunotherapy Market Forecast

• 11.1 Global Immunotherapy Production, Revenue Forecast
  • 11.1.1 Global Immunotherapy Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Immunotherapy Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Immunotherapy Price and Trend Forecast (2019-2025)
• 11.2 Global Immunotherapy Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Immunotherapy Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Immunotherapy Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Immunotherapy Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Immunotherapy Production, Revenue Forecast (2019-2025)
• 11.3 Global Immunotherapy Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Immunotherapy Consumption Forecast (2019-2025)
  • 11.3.2 Europe Immunotherapy Consumption Forecast (2019-2025)
  • 11.3.3 China Immunotherapy Consumption Forecast (2019-2025)
  • 11.3.4 Japan Immunotherapy Consumption Forecast (2019-2025)
• 11.4 Global Immunotherapy Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Immunotherapy Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List